4Ĭonsensus guidelines in the absence of data on patient-oriented outcomes The American Academy of Pediatrics recommends universal screening of newborns ≥ 35 weeks' gestational age with total serum bilirubin or transcutaneous bilirubin at 24 to 48 hours of life or before hospital discharge if occurring earlier. Observational data and consensus guidelines Obtain objective measurements of bilirubin in newborns who appear jaundiced or with symptoms suggestive of bilirubin toxicity. Do not use visual assessment alone to diagnose hyperbilirubinemia. ![]() Phototherapy should be used only for newborns who exceed thresholds recommended by the current AAP hour-specific phototherapy nomograms.Įxamine all newborns for jaundice and signs of acute bilirubin encephalopathy at least every 12 hours from birth until hospital discharge. Mothers of infants who develop jaundice are also more likely to stop breastfeeding, even though discontinuation is not necessary. Phototherapy decreases the need for an exchange transfusion but has the potential for short- and long-term adverse effects, including diarrhea and increased risk of seizures. The AAP also released new nomograms for initiating phototherapy based on gestational age at birth and the presence of neurotoxicity risk factors, with higher thresholds than in previous guidelines. Although universal screening is commonly performed, it increases unnecessary phototherapy use without sufficient evidence that it decreases the incidence of kernicterus. ![]() The American Academy of Pediatrics (AAP) revised its clinical practice guideline in 2022 and reconfirmed its recommendation for universal neonatal hyperbilirubinemia screening in newborns 35 weeks' gestational age or greater. All newborns should be examined regularly, and bilirubin levels should be measured in those who appear jaundiced. It is important to evaluate all newborns for risk factors for bilirubin-related neurotoxicity, and it is reasonable to obtain screening bilirubin levels in newborns with risk factors. However, newborns who are premature or have hemolytic diseases are at higher risk of kernicterus. The irreversible outcome of brain damage from kernicterus is rare (1 out of 100,000 infants) in high-income countries such as the United States, and there is increasing evidence that kernicterus occurs at much higher bilirubin levels than previously thought. ![]() Neonatal jaundice due to hyperbilirubinemia is common, and most cases are benign.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |